S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
NASDAQ:EXFY

Expensify (EXFY) Stock Price, News & Analysis

$1.64
+0.05 (+3.14%)
(As of 04/19/2024 ET)
Today's Range
$1.53
$1.65
50-Day Range
$1.43
$2.49
52-Week Range
$1.40
$8.64
Volume
809,627 shs
Average Volume
641,647 shs
Market Capitalization
$115.75 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.50

Expensify MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
296.3% Upside
$6.50 Price Target
Short Interest
Healthy
3.92% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.80mentions of Expensify in the last 14 days
Based on 13 Articles This Week
Insider Trading
Acquiring Shares
$1.27 M Bought Last Quarter
Proj. Earnings Growth
Growing
From ($0.19) to ($0.06) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.58 out of 5 stars

Business Services Sector

111th out of 305 stocks

Prepackaged Software Industry

81st out of 197 stocks

EXFY stock logo

About Expensify Stock (NASDAQ:EXFY)

Expensify, Inc. provides a cloud-based expense management software platform to individuals and corporations, small and midsized businesses, and enterprises in the United States and internationally. The company's platform enables users to manage corporate cards, pay bills, generate invoices, collect payments, and book travel. It also offers track and submit plans for individuals. The company was founded in 2008 and is based in Portland, Oregon.

EXFY Stock Price History

EXFY Stock News Headlines

Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
JMP Securities Keeps Their Hold Rating on Expensify (EXFY)
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Expensify executive buys shares worth over $466k
EXFY Apr 2024 2.500 call
Expensify CEO sells shares worth over $15,000
Expensify to Participate in Upcoming Investor Event
Expensify: Q4 Earnings Insights
Expensify Announces Q4 and Full Year Fiscal 2023 Results
EXFY Mar 2024 2.500 call
See More Headlines
Receive EXFY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Expensify and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/22/2024
Today
4/19/2024
Next Earnings (Estimated)
5/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Prepackaged software
Sub-Industry
N/A
Current Symbol
NASDAQ:EXFY
Fax
N/A
Employees
133
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$6.50
High Stock Price Target
$12.00
Low Stock Price Target
$2.00
Potential Upside/Downside
+322.1%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
8 Analysts

Profitability

Net Income
$-41,460,000.00
Pretax Margin
-25.53%

Debt

Sales & Book Value

Annual Sales
$150.69 million
Book Value
$1.46 per share

Miscellaneous

Free Float
56,238,000
Market Cap
$108.69 million
Optionable
Optionable
Beta
1.49
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

  • Mr. David Barrett (Age 47)
    Founder, CEO, President & Director
    Comp: $1.61M
  • Mr. Ryan Schaffer (Age 36)
    CFO & Director
    Comp: $873.09k
  • Ms. Anuradha Muralidharan (Age 40)
    COO & Director
    Comp: $460.59k
  • Mr. Jason Fahr Mills (Age 42)
    Chief Product Officer & Director
  • Mr. Daniel Vidal (Age 35)
    Chief Strategy Officer & Director
  • Cole Eason
    Secretary

EXFY Stock Analysis - Frequently Asked Questions

Should I buy or sell Expensify stock right now?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Expensify in the last twelve months. There are currently 2 sell ratings, 4 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" EXFY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in EXFY, but not buy additional shares or sell existing shares.
View EXFY analyst ratings
or view top-rated stocks.

What is Expensify's stock price target for 2024?

8 analysts have issued 1 year target prices for Expensify's stock. Their EXFY share price targets range from $2.00 to $12.00. On average, they predict the company's stock price to reach $6.50 in the next twelve months. This suggests a possible upside of 296.3% from the stock's current price.
View analysts price targets for EXFY
or view top-rated stocks among Wall Street analysts.

How have EXFY shares performed in 2024?

Expensify's stock was trading at $2.47 at the beginning of 2024. Since then, EXFY stock has decreased by 33.6% and is now trading at $1.64.
View the best growth stocks for 2024 here
.

Are investors shorting Expensify?

Expensify saw a drop in short interest in March. As of March 31st, there was short interest totaling 1,700,000 shares, a drop of 18.3% from the March 15th total of 2,080,000 shares. Based on an average trading volume of 646,100 shares, the days-to-cover ratio is currently 2.6 days. Currently, 3.9% of the shares of the company are sold short.
View Expensify's Short Interest
.

When is Expensify's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024.
View our EXFY earnings forecast
.

How were Expensify's earnings last quarter?

Expensify, Inc. (NASDAQ:EXFY) announced its quarterly earnings results on Thursday, February, 22nd. The company reported ($0.09) earnings per share for the quarter, missing analysts' consensus estimates of ($0.03) by $0.06. The firm earned $35.20 million during the quarter, compared to the consensus estimate of $36.85 million. Expensify had a negative net margin of 27.70% and a negative trailing twelve-month return on equity of 41.91%. The business's revenue for the quarter was down 19.1% compared to the same quarter last year. During the same period last year, the firm earned ($0.04) earnings per share.

When did Expensify IPO?

Expensify (EXFY) raised $234 million in an initial public offering (IPO) on Wednesday, November 10th 2021. The company issued 9,730,776 shares at $23.00-$25.00 per share.

How do I buy shares of Expensify?

Shares of EXFY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:EXFY) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners